| Lysophosphatidic acid signaling in cancer cells: what makes LPA so special? P Balijepalli, CC Sitton, KE Meier Cells 10 (8), 2059, 2021 | 33 | 2021 |
| From outside to inside and back again: the lysophosphatidic acid-CCN axis in signal transduction P Balijepalli, KE Meier Journal of Cell Communication and Signaling 17 (3), 845-849, 2023 | 2 | 2023 |
| 10th international workshop on the CCN family of genes, Niagara Falls, Canada, October 21–24, 2019 A Perbal Journal of Cell Communication and Signaling 14 (3), 271-281, 2020 | 2 | 2020 |
| Role for CCN1 in lysophosphatidic acid response in PC‐3 human prostate cancer cells P Balijepalli, BK Knode, SA Nahulu, EL Abrahamson, MP Nivison, ... Journal of Cell Communication and Signaling 18 (1), e12019, 2024 | 1 | 2024 |
| Global proteomics analysis of lysophosphatidic acid signaling in PC-3 human prostate cancer cells: Role of CCN1 P Balijepalli, G Yue, B Prasad, KE Meier International Journal of Molecular Sciences 25 (4), 2067, 2024 | 1 | 2024 |
| Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?. Cells 2021, 10, 2059 P Balijepalli, CC Sitton, KE Meier s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
| Effects of lycopene on growth factor response in prostate cancer cells M Nivison, A VanderWilde, P Balijepalli, KE Meier The FASEB Journal 34 (S1), 1-1, 2020 | 1 | 2020 |
| Characterization of Lysophospholipase D Activity in Mammalian Cell Membranes Y Xie, KM Ella, TC Gibbs, ME Yohannan, SM Knoepp, P Balijepalli, ... Cells 13 (6), 520, 2024 | | 2024 |
| CCN proteins as Downstream Components of Lysophosphatidic Acid Signaling in Prostate Cancer Cells P Balijepalli, B Knode, K Meier Journal of Biological Chemistry 299 (3), 104427, 2023 | | 2023 |
| Roles for CCN proteins in Lysophosphatidic Acid and Sphingosine 1‐Phosphate Signaling in Prostate Cancer Cells P Balijepalli, BK Knode, SA Nahulu, KE Meier The FASEB Journal 36, 2022 | | 2022 |
| Effects of Lysophosphatidic Acid Receptor and Free Fatty Acid Receptor Agonists on CCN1/Cyr61 Expression in Prostate Cancer Cells Kathryn Meier,Pravita Balijepalli FASEB 35, 2021 | | 2021 |
| Effects of Lysophosphatidic Acid Receptor and Free Fatty Acid Receptor Agonists on CCN1/Cyr61 Expression in Prostate Cancer Cells P Balijepalli, K Meier The FASEB Journal 35, 2021 | | 2021 |
| Effects of Lysophosphatidi Acid Receptor and Free Fatty Acid Receptor Agonists on CCN1/Cyr61 Expression P Balijepalli, K Meier FASEB JOURNAL 35, 2021 | | 2021 |
| Effects of Growth Factors and FFAR Agonists on CCN1 Expression in Breast and Prostate Cancer Cells P Balijepalli, MP NIVISON, KE Meier The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| EVALUATION OF AN ELECTRONIC DAILY DIARY FOR MEASURING SYMPTOMS AND IMPACT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. K Kulich, B Tiplady, D Banerji ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY 113 (5), A104-A104, 2014 | | 2014 |
| CHARACTERIZATION OF ROLES OF THE LYSOPHOSPHATIDIC ACID-CCN1 SIGNALING AXIS IN HUMAN PROSTATE CANCER CELLS P Balijepalli Washington State University, 0 | | |
| QVA149 (indacaterol/glycopyrronium) provides significant symptomatic benefit to COPD patients as measured by a new symptom e-diary: the ShINE study LS Mean | | |
